No article text was recorded for this version.
immunosuppressive tumor microenvironment
Version 1 of 1299 papers385 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Acquisition of discrete immune suppressive barriers contributes to the initiation and progression of preinvasive to invasive human lung cancer
- Blog: Next-generation immunotherapy biologics for glioblastoma
- Blog: Research progress and design optimization of CAR‐T therapy for pancreatic ductal adenocarcinoma
- Blog: Blockade of CCR5<sup>+</sup> T Cell Accumulation in the Tumor Microenvironment Optimizes Anti‐TGF‐β/PD‐L1 Bispecific Antibody
- Blog: Tumor Environment Regression Therapy Implemented by Switchable Prune‐to‐Essence Nanoplatform Unleashed Systemic Immune Responses
- Blog: Identification of a TIGIT-expressing CD8+ T cell subset as a potential prognostic biomarker in colorectal cancer
- Blog: Exogenous HMGB1 promotes pancreatic cancer progression by supporting the crosstalk between tumor and myeloid-derived suppressor cell
- Blog: Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue
- Blog: Integrative analysis reveals a macrophage-predominant, immunosuppressive immune microenvironment and subtype-specific therapeutic vulnerabilities in advanced salivary gland cancer
- Blog: Targeting the CSF1/CSF1R signaling pathway: an innovative strategy for ultrasound combined with macrophage exhaustion in pancreatic cancer therapy
- Blog: Ratio of the interferon- <i>γ</i> signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma
- Blog: Landscape of Metabolite-Protein Interaction Networks Reveals Prognostic Subtypes of Ovarian Cancer
- Blog: Evaluation of PD-1 and interleukin-10-receptor expression by T lymphocytes in malignant and benign pleural effusions
- Blog: Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors
- Blog: Regulatory T-Cells and Associated Pathways in Metastatic Renal Cell Carcinoma (mRCC) Patients Undergoing DC-Vaccination and Cytokine-Therapy
- Blog: Prognostic and therapeutic relevance of IL2RG-related LncRNAs in clear cell renal cell carcinoma
- Blog: Integrative transcriptomic and single-cell analyses identify KLRD1 enrichment in exhausted CD8⁺ T cells in cutaneous squamous cell carcinoma
- Blog: Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages
- Blog: Pan-cancer and machine learning reveal the role of cell adhesion molecules in prognosis, immune remodeling, and anti-tumour therapy in lower-grade gliomas
- Blog: 435 ES038, a novel NKCE molecule targeting LILRB4 in AML via dual engagement of NKG2A and NKG2C
- Blog: Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application
- Blog: Modeling tumor progression in heterogeneous microenvironments: A cellular automata approach
- Blog: The Application of Dendritic Cells Vaccines in Tumor Therapy and Their Combination with Biomimetic Nanoparticles
- Blog: Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial
- Blog: Immune Microenvironment Dysregulation: A Contributing Factor to Obesity-Associated Male Infertility
- Blog: Comprehensive analysis of the biological functions of endoplasmic reticulum stress in prostate cancer
- Blog: Emerging mechanisms progress of colorectal cancer liver metastasis
- Blog: TEDC2 correlated with prognosis and immune microenvironment in lung adenocarcinoma
- Blog: ENPP1 is an innate immune checkpoint of the anticancer cGAMP–STING pathway in breast cancer
- Blog: A CD8αβ co-receptor modified to contain an intracellular CD28 signaling tail enhances TCR-engineered T cell function independent of solid-tumor-associated co-stimulatory ligands
- Blog: Prognostic Significance of a 9-Gene Signature Related to Tertiary Lymphoid Structures in Male Stomach Adenocarcinoma Patients
- Blog: The nonsteroidal anti-inflammatory drug sulindac reverses obesity-driven immunosuppression and triple-negative breast cancer progression
- Blog: IDDF2020-ABS-0201 Targeting hepatoma-intrinsic pparγ signaling overcomes immune checkpoint therapy resistance by inflaming the tumor microenvironment
- Blog: Ectopic expression of chemokines and chemokine receptors in relation to immune cell infiltration, prostate cancer recurrence
- Blog: Single‐cell transcriptomic analysis deciphers key transitional signatures associated with oncogenic evolution in human intramucosal oesophageal squamous cell carcinoma
- Blog: Expression of intra-tumoral necrosis-associated cytokine pattern correlated with prognosis and immune status in glioma
- Blog: Interruption of the Intratumor CD8:Treg Crosstalk Improves the Efficacy of PD-1 Immunotherapy
- Blog: Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma
- Blog: Single-cell sequencing reveals effects of chemotherapy on the immune landscape and TCR/BCR clonal expansion in a relapsed ovarian cancer patient
- Blog: mRNA Vaccines: a Powerful Tool in Cancer Treatment
- Blog: Ovarian cancer stem cells: Critical roles in anti-tumor immunity
- Blog: PD-1 and TIGIT Are Highly Co-Expressed on CD8+ T Cells in AML Patient Bone Marrow
- Blog: Programmed cell death-driven remodeling of the melanoma microenvironment enables prognostic stratification and therapeutic prediction
- Blog: Exploring the mechanisms of CD19 CAR T-cell failure and salvage strategies in B-cell lymphoma
- Blog: Adoptive cell therapy for cancer treatment
- Blog: A focal adhesion kinase-YAP signaling axis drives drug tolerant persister cells and residual disease in lung cancer
- Blog: Desmoplastic small round cell tumor: from genomics to targets, potential paths to future therapeutics
- Blog: N6-methylandenosine-related immune genes correlate with prognosis and immune landscapes in gastric cancer
- Blog: Immune infiltration in aggressive papillary craniopharyngioma: High infiltration but low action
- Blog: Validation and identification of anoikis-related lncRNA signatures for improving prognosis in clear cell renal cell carcinoma
- Blog: Targeting STAT3 abrogates Tim-3 upregulation of adaptive resistance to PD-1 blockade on regulatory T cells of melanoma
- Blog: Wnt Inhibition Sensitizes PD-L1 Blockade Therapy by Overcoming Bone Marrow-Derived Myofibroblasts-Mediated Immune Resistance in Tumors
- Blog: tRNA‐Derived Fragment <i>tRF‐22</i> Promotes Immunosuppression by Inhibiting HnRNPAB Ubiquitination in Esophageal Squamous Cell Carcinoma
- Blog: Inhibition of PIM kinase in tumor associated macrophages suppresses inflammasome activation and sensitizes prostate cancer to immunotherapy
- Blog: G-CSF Secreted by Epigenetically Reprogrammed Mutant IDH1 Glioma Stem Cells Reverses the Myeloid Cells’-Mediated Immunosuppressive Tumor Microenvironment
- Blog: Caveolin-1 promotes glioma progression and maintains its mitochondrial inhibition resistance
- Blog: Metformin activates the STING/IRF3/IFN-β pathway by inhibiting AKT phosphorylation in pancreatic cancer.
- Blog: Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growth
- Blog: Tumors induce <i>de novo</i> steroid biosynthesis in T cells to evade immunity
- Blog: Bone Marrow Tumor Microenvironment of Obese Hodgkin Lymphoma Patients: implications of insulin axis
Showing 60 of 299 papers.
History & citation
Current · Permanent link
- Reprogramming the Immunosuppressive Microenvironment to Restore Antitumor Immunity merged into this direction (85% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_immunosuppressive_tumor_microenvironment_1464ab7d,
title = {immunosuppressive tumor microenvironment},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/immunosuppressive-tumor-microenvironment/rdr_1464ab7dc0184745b4ae65199dae0896},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 1, frozen text):
@misc{lacuna_immunosuppressive_tumor_microenvironment_1464ab7d_v1,
title = {immunosuppressive tumor microenvironment},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/immunosuppressive-tumor-microenvironment/rdr_1464ab7dc0184745b4ae65199dae0896/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}